This week in Washington IP news, the Senate Judiciary Committee will consider a series of bills that could limit pharmaceutical patent owners’ ability to enforce their patents against generic drug makers. Over in the House of Representatives, the House Science Committee will mark up a series of bills to support research and development as well as technology transfer and commercialization, while the House Europe Subcommittee will explore international case studies in offshore wind renewable energy innovation. Elsewhere, the American Enterprise Institute focuses on developments in the private commercial space sector, while the USPTO celebrates 75 years of the Lanham Act’s codification of U.S. trademark law this Tuesday.
Recent Posts
- Mixed UK High Court Ruling Fails to Answer Fundamental Questions of AI Copyright Infringement
- Professors Press SCOTUS to Affirm Copyright Protection for AI-Created Works
- Squires Emphasizes AI, Dubs Inherited Backlog ‘An Absolute Dumpster Fire’ and a ‘Betrayal’
- Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’
- Squires Restores PTAB’s RPI Identification Requirement to Exacting Pre-SharkNinja Standard